Divalproex sodium versus valproic acid in hospital treatment of psychotic disorders

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 2, Issue 2, 2000, Pages 45-48

  Schwartz, Thomas L ^a   Massa, Jose L ^a   Gupta, Sanjay ^b   Al Samarrai, Sadiq ^c   Devitt, Patrick ^a   Masand, Prakash S ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b Olean Hospital   (United States)

^c Cattaraugus County Continuing Day Treatment Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 20344371319     PISSN: 15235998     EISSN: None     Source Type: Journal    
DOI: 10.4088/PCC.v02n0203     Document Type: Article

References (9)

1. Johnson KT. Generic drugs are good medicine. PCS Health Systems: Clin Pharm Rev 1997;7:1-3
2. Reifman A, Wyatt RJ. Lithium: a brake in the rising cost of mental illness. Arch Gen Psychiatry 1980;37:385-388
3. Cranor CW, Sawyer WT, Carson SW, et al. Clinical and economic impact of replacing divalproex sodium with valproic acid. Am J Health Syst Pharm 1997;54:1716-1722
4. Depakene [package insert]. Chicago, 111: Abbott Laboratories; 1995
5. Depakote [package insert]. Chicago, 111: Abbott Laboratories; 1995
6. Keck PE. The use of divalproex. J Clin Psychiatry Monograph 1997;15(4):18-19
7. Feldstein JH, Curtis JL. Update on the costs of Depakote and Depakene. Ment Retard 1995;33:62
8. Smart JR. Divalproex sodium: a cost-effective alternative in long-term care. Consult Pharm 1995;10:533
9. Sherr DL, Kelly DL. Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients. Psychiatr Serv 1998;49:1355-1357